STELLATE Trademark

Trademark Overview


On Wednesday, January 15, 2020, a trademark application was filed for STELLATE with the United States Patent and Trademark Office. The USPTO has given the STELLATE trademark a serial number of 88760508. The federal status of this trademark filing is ABANDONED - NO STATEMENT OF USE FILED as of Monday, February 14, 2022. This trademark is owned by Amabiotics Inc.. The STELLATE trademark is filed in the Pharmaceutical Products and Computer & Software Services & Scientific Services categories with the following description:

pharmaceutical preparations and therapeutics for the treatment of neurodegenerative diseases and disorders, neurological diseases and disorders, microbiome-related conditions, diseases and disorders related to the gut-brain axis, Alzheimer's disease, Parkinson's disease, Ataxia, Huntington's disease, and amyotrophic lateral sclerosis (ALS)

Pharmaceutical research and development; medical and scientific research in the fields of neurodegenerative diseases and disorders, neurological diseases and disorders, microbiome-related conditions, diseases and disorders related to the gut-brain axis, Alzheimer's disease, Parkinson's disease, Ataxia, Huntington's disease, and amyotrophic lateral sclerosis (ALS)
stellate

General Information


Serial Number88760508
Word MarkSTELLATE
Filing DateWednesday, January 15, 2020
Status606 - ABANDONED - NO STATEMENT OF USE FILED
Status DateMonday, February 14, 2022
Registration Number0000000
Registration DateNOT AVAILABLE
Mark Drawing4000 - Illustration: Drawing with word(s) / letter(s) / number(s) in Block form
Published for Opposition DateTuesday, May 19, 2020

Trademark Statements


Goods and Servicespharmaceutical preparations and therapeutics for the treatment of neurodegenerative diseases and disorders, neurological diseases and disorders, microbiome-related conditions, diseases and disorders related to the gut-brain axis, Alzheimer's disease, Parkinson's disease, Ataxia, Huntington's disease, and amyotrophic lateral sclerosis (ALS)
Goods and ServicesPharmaceutical research and development; medical and scientific research in the fields of neurodegenerative diseases and disorders, neurological diseases and disorders, microbiome-related conditions, diseases and disorders related to the gut-brain axis, Alzheimer's disease, Parkinson's disease, Ataxia, Huntington's disease, and amyotrophic lateral sclerosis (ALS)

Classification Information


International Class005 - Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes; dietetic substances adapted for medical use, food for babies; plasters, materials for dressings; material for stopping teeth, dental wax; disinfectants; preparations for destroying vermin; fungicides, herbicides.
US Class Codes006, 018, 044, 046, 051, 052
Class Status Code6 - Active
Class Status DateWednesday, January 22, 2020
Primary Code005
First Use Anywhere DateNOT AVAILABLE
First Use In Commerce DateNOT AVAILABLE

International Class042 - Scientific and technological services and research and design relating thereto; industrial analysis and research services; design and development of computer hardware and software.
US Class Codes100, 101
Class Status Code6 - Active
Class Status DateWednesday, January 22, 2020
Primary Code042
First Use Anywhere DateNOT AVAILABLE
First Use In Commerce DateNOT AVAILABLE

Trademark Owner History


Party NameSTELLATE THERAPEUTICS INC.
Party Type22 - New Owner After Publication
Legal Entity Type03 - Corporation
AddressNEW YORK, NY 10013

Party NameSTELLATE THERAPEUTICS INC.
Party Type21 - New Owner After Publication
Legal Entity Type03 - Corporation
AddressNew York, NY 10013

Party NameAmabiotics Inc.
Party Type20 - Owner at Publication
Legal Entity Type03 - Corporation
AddressNew York, NY 10013

Party NameAmabiotics Inc.
Party Type10 - Original Applicant
Legal Entity Type03 - Corporation
AddressNew York, NY 10013

Trademark Events


Event DateEvent Description
Monday, February 14, 2022ABANDONMENT NOTICE E-MAILED - NO USE STATEMENT FILED
Monday, February 14, 2022ABANDONMENT - NO USE STATEMENT FILED
Friday, July 16, 2021NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Wednesday, July 14, 2021EXTENSION 2 GRANTED
Wednesday, July 14, 2021EXTENSION 2 FILED
Wednesday, July 14, 2021TEAS EXTENSION RECEIVED
Thursday, February 4, 2021NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Wednesday, February 3, 2021AUTOMATIC UPDATE OF ASSIGNMENT OF OWNERSHIP
Wednesday, February 3, 2021EXTENSION 1 GRANTED
Friday, January 8, 2021EXTENSION 1 FILED
Thursday, January 28, 2021CASE ASSIGNED TO INTENT TO USE PARALEGAL
Friday, January 8, 2021TEAS EXTENSION RECEIVED
Tuesday, July 14, 2020NOA E-MAILED - SOU REQUIRED FROM APPLICANT
Tuesday, May 19, 2020OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Tuesday, May 19, 2020PUBLISHED FOR OPPOSITION
Wednesday, April 29, 2020NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
Monday, April 6, 2020APPROVED FOR PUB - PRINCIPAL REGISTER
Thursday, April 2, 2020ASSIGNED TO EXAMINER
Wednesday, January 22, 2020NEW APPLICATION OFFICE SUPPLIED DATA ENTERED IN TRAM
Saturday, January 18, 2020NEW APPLICATION ENTERED IN TRAM